Delivery Order SPE2DB20D1100-SPE2DB24FC5X2

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,402.91, is a Firm Fixed Price Delivery Order for the supply of Abiraterone Acetate 500 mg tablets. The contract has an ultimate completion date of February 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,420.28, is for the delivery of abiraterone acetate 250 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,733.10, is for the delivery of 4,567,313,202 units of abiraterone acetate 250 mg tablets. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 20, 2025. This contract award is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of abiraterone acetate 250 mg tablets. The contract has a ceiling value of $1,610.20 and a completion date of February 26, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,082.28, is for the delivery of 4,563,885,927 units of Abiraterone Acetate 250 mg tablets. The contract has a completion date of March 8, 2024 and is a Firm Fixed Price Delivery Order. The award was made on March 7, 2024 and there was no set-aside designation used. AmerisourceBergen Drug Corp holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,570,695 units of Abiraterone Acetate 500 mg tablets. The contract has a ceiling value of $14,550.27 and a period of performance through December 2, 2024. This contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets. The contract, valued at $94,299.16, has a period of performance through January 8, 2025 and utilizes a firm fixed-price pricing type. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price of $37,956.32 to AmerisourceBergen Drug Corp for the supply of 4,566,674,785 units of the pharmaceutical product Abiraterone Acetate 500 mg tablets. The award has an ultimate completion date of December 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,804.99 firm-fixed-price delivery order is for 4,567,025,743 units of Abiraterone Acetate 500 mg tablets. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of abiraterone acetate 250 mg tablets. The contract, valued at $13,348.20, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC5X2
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Abiraterone Acetate 500mg tablets, a prescription medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,920.00 and an ultimate completion date of July 8, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award is a delivery order placed against this larger IDC. The contract does not have a set-aside designation.

Generated 10/4/24, 9:11 AM